Company · CIK 0001388320
Actinium Pharmaceuticals, Inc.
ATNMSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.32+$0.19 (+16.81%)
ATNM · Last trade
- Prev close
- $1.13
- Range (28d)
- $0.98 – $1.32
On the record
Recent filings
- 8-KATNMCurrent report0001213900-26-109884 · 224.4 KBSEC(opens sec.gov)
- 8-KATNMCurrent report0001213900-26-090232 · 259.9 KBSEC(opens sec.gov)
- 10-QATNMQuarterly update0001213900-26-086769 · 10.1 MBSEC(opens sec.gov)
- 8-KATNMCurrent report0001213900-26-070193 · 185.7 KBSEC(opens sec.gov)
- 8-KATNMCurrent report0001213900-26-062935 · 230.9 KBSEC(opens sec.gov)
- 10-QATNMQuarterly update0001213900-26-053980 · 5.2 MBSEC(opens sec.gov)
- 10-KATNMAnnual report0001213900-26-036504 · 9.3 MBSEC(opens sec.gov)
- 8-K/AATNMActinium Pharmaceuticals, Inc.0001213900-26-034807 · 194.9 KBSEC(opens sec.gov)
- 8-KATNMCurrent report0001213900-26-016559 · 191.0 KBSEC(opens sec.gov)
- 8-KATNMCurrent report0001213900-25-115586 · 201.9 KBSEC(opens sec.gov)
Insiders
- Almenoff June SherieDirector
- Berger Mark StanleyChief Medical Officer
- Chell Jeffrey W.Director
- CICIC DRAGANChief Technology Officer
- DAVE KAUSHIK JDirector, CEO and Interim CFO
- David Matthew TChief Financial Officer
- GUAGENTI ENZAChief Financial Officer
- Heeger Steffen WilhemChief Medical Officer
- Kamal AdeelaChief Scientific Officer
- Kapur AnilChief Commercial Officer
Tickers
Addresses
business
100 PARK AVE., 23RD FLOOR
NEW YORK, NY, 10017
mailing
100 PARK AVE., 23RD FLOOR
NEW YORK, NY, 10017
Former names
- Cactus Ventures, Inc.2013-03-29
Same industry